Evidence map›Paper›PMID 39233564›Full record

ArticleRNA biology2024

Poly(G)

Dahao Wei, Zhangyu Mai, Xinan Li, Tianli Yu, Jiangchao Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RNA biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dahao WeiSchool of Life Sciences and Biopharmaceuticals, Guangdong Pharmaceutical University, Guangzhou, China.
Zhangyu MaiSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, China.
Xinan LiLaboratory of Oncology and Immunology, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
Tianli YuLaboratory of Oncology and Immunology, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou, China.
Jiangchao LiLaboratory of Oncology and Immunology, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou, China.ORCID 0000-0002-0947-7580

Funding

National Key R&D Program, China 2021YFF0702600Science and Technology Planning Project of Guangdong Province, China 2023A0505050153
6 · The paper itself

Abstract

In eukaryotes, the ribosomal small subunit (40S) is composed of 18S rRNA and 33 ribosomal proteins. 18S rRNA has a special secondary structure and is an indispensable part of the translation process. Herein, a special sequence located in mammalian 18S rRNA named Poly(G)

Indexed as

Protein BiosynthesisRNA, Ribosomal, 18SAnimalsBase SequenceGuanineHumansMammalsNucleic Acid ConformationRibosomal ProteinsRNA, MessengerGuanineRibosomal ProteinsRNA, MessengerRNA, Ribosomal, 18S18S rRNAConserved sequencePoly(G)7boxRibosomeTranslation regulatory elements

Identifiers

PMID39233564
PMCPMC11382726

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.